Home LiteratureArticle Details
PMID: 9026483 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.

Gut ·Vol. 39 ·No. 5 ·1996-11-00 ·Pages 684-9

Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, Duclos B

Abstract

Increasing evidence points to a important role for inflammatory cytokines for the pathogenesis of Crohn's disease. To compare the secretion rate of tumour necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) by morphologically normal and inflamed intestinal mucosa from patients with Crohn's disease. Organ cultures of intestinal biopsy specimens taken from areas of affected mucosa from patients with Crohn's disease spontaneously produced increased amounts of TNF-alpha, IL-1 beta, and IL-6 compared with controls but also biopsy specimens taken in macroscopically and microscopically unaffected areas in the same patients. Concentrations of IL-1 beta and IL-6 measured in the supernatant fluid of biopsy cultures were positively correlated with the degree of tissue involvement measured by both endoscopic and histological grading. By contrast, TNF-alpha concentrations were not correlated to endoscopic and histological grading. These consistently raised TNF-alpha, IL-1 beta and IL-6 secretions by normal appearing mucosa from patients with Crohn's disease provide evidence for a sustained immune stimulation in Crohn's disease even in the absence of patent inflammation. The results shed a new light on the role of inflammatory cytokines in the onset of intestinal tissue damage in Crohn's disease and suggest that the range of intestinal lesions in Crohn's disease may be wider than suspected on the basis of regular endoscopic and histological examinations.

MeSH Terms
Adult Colon Colonoscopy Crohn Disease/immunology,pathology Enzyme-Linked Immunosorbent Assay Female Humans Ileum Interleukin-1/metabolism Interleukin-6/metabolism Intestinal Mucosa/immunology,pathology Male Middle Aged Monokines/metabolism Organ Culture Techniques Tumor Necrosis Factor-alpha/metabolism
Chemicals
Interleukin-1 Interleukin-6 Monokines Tumor Necrosis Factor-alpha
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Reimund J M
Service d'Hepatogastroentérologie, CHRU Hautepierre, Strasbourg, France.
Wittersheim C
Dumont S
Muller C D
Kenney J S
Baumann R
Poindron P
Duclos B
References (28)
28 references, click to expand
  1. Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.
    Gut. 1990 Jun;31(6):686-9 PMID: 2379873
  2. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
    N Engl J Med. 1990 May 10;322(19):1345-9 PMID: 2325733
  3. Microscopic activity in ulcerative colitis: what does it mean?
    Gut. 1991 Feb;32(2):174-8 PMID: 1864537
  4. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.
    Dig Dis Sci. 1992 Jun;37(6):818-26 PMID: 1587185
  5. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification.
    Gastroenterology. 1992 Nov;103(5):1587-95 PMID: 1426879
  6. Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease.
    Gut. 1992 Dec;33(12):1644-51 PMID: 1487166
  7. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.
    Immunology. 1993 Jan;78(1):127-31 PMID: 8436398
  8. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Clin Exp Immunol. 1993 Oct;94(1):174-81 PMID: 8403503
  9. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.
    Gastroenterology. 1994 Jun;106(6):1455-66 PMID: 8194690
  10. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.
    Gastroenterology. 1995 Jan;108(1):21-33 PMID: 7806044
  11. Cytokines in Crohn's colitis.
    Am J Surg. 1995 Jan;169(1):133-6 PMID: 7817982
  12. Scanning electron-microscopic lesions in Crohn's disease: relevance for the interpretation of postoperative recurrence.
    Gastroenterology. 1995 Feb;108(2):376-82 PMID: 7835578
  13. Apoptosis, oncosis, and necrosis. An overview of cell death.
    Am J Pathol. 1995 Jan;146(1):3-15 PMID: 7856735
  14. Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease.
    Virchows Arch. 1995;426(1):51-60 PMID: 7704324
  15. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent.
    Dig Dis Sci. 1995 May;40(5):949-59 PMID: 7729284
  16. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).
    Gastroenterology. 1995 Jul;109(1):129-35 PMID: 7797011
  17. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
    J Clin Immunol. 1996 May;16(3):144-50 PMID: 8734357
  18. The value of rectal biopsy in the diagnosis of Crohn's disease.
    Scand J Gastroenterol. 1970;5(6):491-6 PMID: 5460411
  19. A method for the quantitation of small intestinal biopsy specimens.
    J Clin Pathol. 1972 Mar;25(3):243-6 PMID: 5018715
  20. Abnormalities in the apparently normal bowel mucosa in Crohn's disease.
    Lancet. 1976 Feb 7;1(7954):275-8 PMID: 55588
  21. Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract.
    Gut. 1977 Apr;18(4):290-4 PMID: 324874
  22. Crohn's disease: a scanning electron microscopic study.
    Hum Pathol. 1979 Mar;10(2):165-77 PMID: 422189
  23. An index of inflammatory activity in patients with Crohn's disease.
    Gut. 1980 Apr;21(4):279-86 PMID: 7429289
  24. Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity.
    J Immunol. 1987 Jun 15;138(12):4236-42 PMID: 2438338
  25. Increased phospholipase A2 activity of Ileal mucosa in Crohn's disease.
    Digestion. 1988;41(3):136-41 PMID: 3224765
  26. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.
    Cell. 1989 Mar 10;56(5):731-40 PMID: 2647299
  27. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.
    Gut. 1989 Jun;30(6):835-8 PMID: 2787769
  28. Predictability of the postoperative course of Crohn's disease.
    Gastroenterology. 1990 Oct;99(4):956-63 PMID: 2394349
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
1996-11-00
Pages
684-9
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1383392
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]